Search research articles
Contact Us
Filters
Showing results (351-360 of 361) with videos related to
Page
of 37
Sort By:
Taiwanese Journal of Obstetrics & Gynecology
|
October 8, 2014
Outcome of patients with bulky IB (≥ 6 cm) cervical squamous cell carcinoma with and without cisplatin-based neoadjuvant chemotherapy
Peng-Hui Wang, Yen-Hou Chang, Ying-Hui Yang, et al.
Medicine
|
April 16, 2016
Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article)
Jen-Ruei Chen, Ting-Chang Chang, Hung-Chun Fu, et al.
Oncotarget
|
December 31, 2015
Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma
Pi-Lin Sung, Yi-Hua Jan, Shih-Chieh Lin, et al.
Journal of Cellular and Molecular Medicine
|
April 25, 2014
Oestrogen-induced angiogenesis promotes adenomyosis by activating the Slug-VEGF axis in endometrial epithelial cells
Tze-Sing Huang, Yi-Jen Chen, Teh-Ying Chou, et al.
Journal of Gynecologic Oncology
|
February 1, 2024
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, et al.
Journal of the Chinese Medical Association : JCMA
|
April 25, 2013
Robertsonian translocations: an overview of a 30-year experience in a single tertiary medical center in Taiwan
Yi-Wen Chang, Ling-Chao Chen, Chih-Yao Chen, et al.
Journal of the Chinese Medical Association : JCMA
|
March 19, 2013
Balanced and unbalanced reciprocal translocation: an overview of a 30-year experience in a single tertiary medical center in Taiwan
Yi-Wen Chang, Peng-Hui Wang, Wai Hou Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2024
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial
Christian Marth, Richard G Moore, Mariusz Bidziński, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 21, 2026
Lenvatinib plus pembrolizumab in participants with advanced or recurrent endometrial cancer: Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomes
Christian Marth, Domenica Lorusso, Mariusz Bidziński, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 31, 2019
An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma
Chen-Lei Wen, Ke Huang, Lu-Lu Jiang, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 361) with videos related to
Sort By:
Page
of 37
Taiwanese Journal of Obstetrics & Gynecology
|
October 8, 2014
Outcome of patients with bulky IB (≥ 6 cm) cervical squamous cell carcinoma with and without cisplatin-based neoadjuvant chemotherapy
Peng-Hui Wang, Yen-Hou Chang, Ying-Hui Yang, et al.
Medicine
|
April 16, 2016
Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article)
Jen-Ruei Chen, Ting-Chang Chang, Hung-Chun Fu, et al.
Oncotarget
|
December 31, 2015
Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma
Pi-Lin Sung, Yi-Hua Jan, Shih-Chieh Lin, et al.
Journal of Cellular and Molecular Medicine
|
April 25, 2014
Oestrogen-induced angiogenesis promotes adenomyosis by activating the Slug-VEGF axis in endometrial epithelial cells
Tze-Sing Huang, Yi-Jen Chen, Teh-Ying Chou, et al.
Journal of Gynecologic Oncology
|
February 1, 2024
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, et al.
Journal of the Chinese Medical Association : JCMA
|
April 25, 2013
Robertsonian translocations: an overview of a 30-year experience in a single tertiary medical center in Taiwan
Yi-Wen Chang, Ling-Chao Chen, Chih-Yao Chen, et al.
Journal of the Chinese Medical Association : JCMA
|
March 19, 2013
Balanced and unbalanced reciprocal translocation: an overview of a 30-year experience in a single tertiary medical center in Taiwan
Yi-Wen Chang, Peng-Hui Wang, Wai Hou Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2024
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial
Christian Marth, Richard G Moore, Mariusz Bidziński, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 21, 2026
Lenvatinib plus pembrolizumab in participants with advanced or recurrent endometrial cancer: Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomes
Christian Marth, Domenica Lorusso, Mariusz Bidziński, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 31, 2019
An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma
Chen-Lei Wen, Ke Huang, Lu-Lu Jiang, et al.
Page
of 37